© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Astrana Health, Inc. (ASTH) shows an Average True Range (ATR) of 1.21 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 469.04K, indicating liquidity. These fundamental metrics provide insight into ASTH's underlying financial health and market activity.
Astrana Health, Inc. (ASTH) technical indicators as of December 22, 2025: the SMA 20 is 5.37%, SMA 50 at -9.62%, and SMA 200 at -13.56%. The RSI 14 value is 51.62, suggesting its current momentum. These technical analysis signals help assess ASTH's price trends and potential future movements.
Astrana Health, Inc. (ASTH) stock performance overview as of December 22, 2025: The 52-week high is $39.97 (currently -40.28% below), and the 52-week low is $20.12 (currently 18.64% above). Over the past year, ASTH's performance is -36.57%, compared to the S&P 500's 12.87% change.
According to market data, Astrana Health, Inc. (ASTH) stock's recent performance metrics show that over the last month, ASTH is 11.65%, with a Year-to-Date (YTD) performance of -24.29%. Over the past year, the stock has seen a -36.57% change. These figures summarize ASTH's price movements across various periods, reflecting its historical returns.
According to current financial data, ASTH stock's P/E (TTM) ratio is 123.11, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for ASTH, including P/S (0.40), P/B (1.51), and P/FCF (12.38), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.